Omeprazol Stada (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Stada, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease, NSAID‑induced ulcers and as part of Helicobacter pylori eradication regimens.

GNH USA supplies Omeprazol Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Stada, a proton pump inhibitor, acts on the gastric acid‑secreting pathway to manage acid‑related disorders. - Gastro‑oesophageal reflux disease: reduces acid exposure, relieving heartburn and regurgitation. - Peptic ulcer disease: promotes ulcer healing by lowering gastric acidity. - NSAID‑induced ulcer: prevents ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs. - Helicobacter pylori eradication: enhances the effectiveness of antibiotic regimens by creating a less acidic gastric environment.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools may appear during treatment. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fracture risk: especially with long‑term use. - Interstitial nephritis: kidney inflammation presenting with fever and rash. - Elevated liver enzymes: signs of hepatic stress.

Before initiating therapy, consider the following safety measures. - Assess renal function: adjust use in severe impairment. - Monitor magnesium: prolonged therapy may cause deficiency. - Review concomitant drugs: avoid known contraindicated combinations. - Use caution in pregnancy: limited data, weigh benefits against risks. - Store at ambient temperature: keep in the original pack, protect from moisture.

Omeprazole can affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Ketoconazole: reduced absorption and efficacy. - Atazanavir: decreased antiviral activity. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Digoxin: potential rise in serum levels, watch for toxicity. - Methotrexate: increased risk of toxicity, especially at high doses.